BibTex RIS Cite

-

Year 2010, Volume: 23 Issue: 2, 290 - 292, 27.04.2015

Abstract

-

References

  • Hall RR, Laurence JR, Neville AM, et al.
  • Carcinoembryonic antigen and urothelial carcinoma.
  • Br J Urol 1972; 45: 88-92.
  • Huland H, Otto U, Droese M. The value of urinary
  • cytology, serum and urinary carcinoembryonic
  • antigen, rheumatoid factors and urinary
  • immunoglobulin concentration as tumor markers or
  • prognostic factors in predicting progression of
  • superficial bladder cancer. Eur Urol 1983; 9: 346-349.
  • Stefanovic V, Mitic-Zlatkovic M, Ignjatovic I, et al.
  • Tissue polypeptide antigen and carcinoembryonic
  • antigen lack diagnostic accuracy in urothelial
  • carcinoma. Int Urol Nephrol 1999; 31: 443-449.
  • Coombers GB, Hall RR, Laurence JR, et al. Urinary
  • carcinoembryonic antigen– like molecules and
  • urothelial malignancy: a clinical appraisal. Br J
  • Cancer 1975; 31: 135-142.
  • Sengupta S, Lohse CM, Cheville JC, et al. The
  • preoperative erythrocyte sedimentation rate is an
  • independent prognostic factor in renal cell carcinoma.
  • Cancer 2006; 106: 304-321.
  • Jakse G, Rauschmeier H, Rosmanith P, et al.
  • Determination of carcinoembryonic antigen in tissue,
  • serum and urine in patients with transitional cell
  • carcinoma of the urinary bladder. Urol Int 1983; 38:
  • -125.
  • Nakatsu H, Kobayashi I, Onishi Y, et al. ABO (H)
  • blood group antigens and carcinoembryonic antigen
  • potential in patients with transitional cell carcinoma
  • of the bladder. J Urol 1984; 131: 252-257.
  • Ikemoto S, Limori H, Nishimoto K, et al. Two cases
  • of urothelial tumor with high serum level of
  • carcinoembryonic antigen and TA-4. Urol Int 1993;
  • : 105-107.
  • Sugaya Y, Ochi M, Hashimoto S, et al. A case of
  • transitional cell carcinoma of renal pelvis with
  • extremely high serum levels of CA 19-9 and CEA.
  • Hinyokika Kiyo 1997; 43: 495-499.
  • Hannisdal E, Fossa SD, Host H. Blood tests and
  • prognosis in bladder carcinomas treated with
  • definitive radiotherapy. Radiother Oncol 1993; 27:
  • -122.

RENAL TRANSİZYONEL HÜCRELİ KARSİNOM İÇİN OLASI SERUM BELİRTEÇLERİ: LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ İLE BİRLİKTE BİR OLGUNUN SUNUMU

Year 2010, Volume: 23 Issue: 2, 290 - 292, 27.04.2015

Abstract

Üriner sistemin üst bölümünün ürotelyal tümörü, relatif olarak nadir görülen malignitelerden biridir. Prostat ve testis kanserlerine özgü serum belirteçleri bilinmesine rağmen, renal ve ürotelyal tümörler için spesifik belirteçlerin tanımlanmasına ihtiyaç vardır. Bu makalede, yüksek preoperatif serum düzeyine sahip Karsinoembryonik antijen (CEA) ve Eritrosit sedimentasyon hızına (ESR) sahip olgu sunulacaktır. Preoperatif metastazı olmayan hastaya uygulanan radikal nefroüreterektomi operasyonu sonrası, histolojik tanı yüksek grade’li renal pelvis ürotelyal karsinomu olarak rapor edilmiştir. Cerrahi sınırlar negatif olup serum CEA ve ESR düzeyinde postoperatif erken dönemde tamamen düzelme görülmüştür.

Anahtar Kelimeler: Karsinoembriyonik antijen, Ürotelyal tümör, Eritrosit Sedimentasyon Hızı, Renal pelvis, Serum belirteçleri

References

  • Hall RR, Laurence JR, Neville AM, et al.
  • Carcinoembryonic antigen and urothelial carcinoma.
  • Br J Urol 1972; 45: 88-92.
  • Huland H, Otto U, Droese M. The value of urinary
  • cytology, serum and urinary carcinoembryonic
  • antigen, rheumatoid factors and urinary
  • immunoglobulin concentration as tumor markers or
  • prognostic factors in predicting progression of
  • superficial bladder cancer. Eur Urol 1983; 9: 346-349.
  • Stefanovic V, Mitic-Zlatkovic M, Ignjatovic I, et al.
  • Tissue polypeptide antigen and carcinoembryonic
  • antigen lack diagnostic accuracy in urothelial
  • carcinoma. Int Urol Nephrol 1999; 31: 443-449.
  • Coombers GB, Hall RR, Laurence JR, et al. Urinary
  • carcinoembryonic antigen– like molecules and
  • urothelial malignancy: a clinical appraisal. Br J
  • Cancer 1975; 31: 135-142.
  • Sengupta S, Lohse CM, Cheville JC, et al. The
  • preoperative erythrocyte sedimentation rate is an
  • independent prognostic factor in renal cell carcinoma.
  • Cancer 2006; 106: 304-321.
  • Jakse G, Rauschmeier H, Rosmanith P, et al.
  • Determination of carcinoembryonic antigen in tissue,
  • serum and urine in patients with transitional cell
  • carcinoma of the urinary bladder. Urol Int 1983; 38:
  • -125.
  • Nakatsu H, Kobayashi I, Onishi Y, et al. ABO (H)
  • blood group antigens and carcinoembryonic antigen
  • potential in patients with transitional cell carcinoma
  • of the bladder. J Urol 1984; 131: 252-257.
  • Ikemoto S, Limori H, Nishimoto K, et al. Two cases
  • of urothelial tumor with high serum level of
  • carcinoembryonic antigen and TA-4. Urol Int 1993;
  • : 105-107.
  • Sugaya Y, Ochi M, Hashimoto S, et al. A case of
  • transitional cell carcinoma of renal pelvis with
  • extremely high serum levels of CA 19-9 and CEA.
  • Hinyokika Kiyo 1997; 43: 495-499.
  • Hannisdal E, Fossa SD, Host H. Blood tests and
  • prognosis in bladder carcinomas treated with
  • definitive radiotherapy. Radiother Oncol 1993; 27:
  • -122.
There are 42 citations in total.

Details

Primary Language Turkish
Journal Section Case Reports
Authors

Hüsnü Tokgöz This is me

Özlem Türksoy This is me

Bülent Erol This is me

Publication Date April 27, 2015
Published in Issue Year 2010 Volume: 23 Issue: 2

Cite

APA Tokgöz, H., Türksoy, Ö., & Erol, B. (2015). RENAL TRANSİZYONEL HÜCRELİ KARSİNOM İÇİN OLASI SERUM BELİRTEÇLERİ: LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ İLE BİRLİKTE BİR OLGUNUN SUNUMU. Marmara Medical Journal, 23(2), 290-292.
AMA Tokgöz H, Türksoy Ö, Erol B. RENAL TRANSİZYONEL HÜCRELİ KARSİNOM İÇİN OLASI SERUM BELİRTEÇLERİ: LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ İLE BİRLİKTE BİR OLGUNUN SUNUMU. Marmara Med J. August 2015;23(2):290-292.
Chicago Tokgöz, Hüsnü, Özlem Türksoy, and Bülent Erol. “RENAL TRANSİZYONEL HÜCRELİ KARSİNOM İÇİN OLASI SERUM BELİRTEÇLERİ: LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ İLE BİRLİKTE BİR OLGUNUN SUNUMU”. Marmara Medical Journal 23, no. 2 (August 2015): 290-92.
EndNote Tokgöz H, Türksoy Ö, Erol B (August 1, 2015) RENAL TRANSİZYONEL HÜCRELİ KARSİNOM İÇİN OLASI SERUM BELİRTEÇLERİ: LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ İLE BİRLİKTE BİR OLGUNUN SUNUMU. Marmara Medical Journal 23 2 290–292.
IEEE H. Tokgöz, Ö. Türksoy, and B. Erol, “RENAL TRANSİZYONEL HÜCRELİ KARSİNOM İÇİN OLASI SERUM BELİRTEÇLERİ: LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ İLE BİRLİKTE BİR OLGUNUN SUNUMU”, Marmara Med J, vol. 23, no. 2, pp. 290–292, 2015.
ISNAD Tokgöz, Hüsnü et al. “RENAL TRANSİZYONEL HÜCRELİ KARSİNOM İÇİN OLASI SERUM BELİRTEÇLERİ: LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ İLE BİRLİKTE BİR OLGUNUN SUNUMU”. Marmara Medical Journal 23/2 (August 2015), 290-292.
JAMA Tokgöz H, Türksoy Ö, Erol B. RENAL TRANSİZYONEL HÜCRELİ KARSİNOM İÇİN OLASI SERUM BELİRTEÇLERİ: LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ İLE BİRLİKTE BİR OLGUNUN SUNUMU. Marmara Med J. 2015;23:290–292.
MLA Tokgöz, Hüsnü et al. “RENAL TRANSİZYONEL HÜCRELİ KARSİNOM İÇİN OLASI SERUM BELİRTEÇLERİ: LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ İLE BİRLİKTE BİR OLGUNUN SUNUMU”. Marmara Medical Journal, vol. 23, no. 2, 2015, pp. 290-2.
Vancouver Tokgöz H, Türksoy Ö, Erol B. RENAL TRANSİZYONEL HÜCRELİ KARSİNOM İÇİN OLASI SERUM BELİRTEÇLERİ: LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ İLE BİRLİKTE BİR OLGUNUN SUNUMU. Marmara Med J. 2015;23(2):290-2.